2020 Q4 Form 10-K Financial Statement

#000156459021017090 Filed on March 31, 2021

View on sec.gov

Income Statement

Concept 2020 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$34.10K
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$34.10K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $9.704M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $21.43M
Other Receivables
Total Short-Term Assets $34.35M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $863.0K
YoY Change
Goodwill $0.00
YoY Change
Intangibles $90.50M
YoY Change
Long-Term Investments
YoY Change
Other Assets $593.0K
YoY Change
Total Long-Term Assets $184.0M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $34.35M
Total Long-Term Assets $184.0M
Total Assets $218.4M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.731M
YoY Change
Accrued Expenses $7.270M
YoY Change
Deferred Revenue $541.0K
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $1.100M
YoY Change
Total Short-Term Liabilities $12.06M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $105.9M
YoY Change
Other Long-Term Liabilities $19.00K
YoY Change
Total Long-Term Liabilities $105.9M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $12.06M
Total Long-Term Liabilities $105.9M
Total Liabilities $118.0M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$7.838M
YoY Change
Common Stock $108.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.4M
YoY Change
Total Liabilities & Shareholders Equity $218.4M
YoY Change

Cashflow Statement

Concept 2020 Q4
OPERATING ACTIVITIES
Net Income -$34.10K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 150.0K
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities 150.0K
Net Change In Cash 150.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001836981
CY2020Q4 dei City Area Code
CityAreaCode
(650)
CY2020Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45949600
CY2020Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q4 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 dei Entity File Number
EntityFileNumber
001-40031
CY2020Q4 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q4 dei Document Type
DocumentType
10-K
CY2020Q4 dei Entity Registrant Name
EntityRegistrantName
GigCapital4, Inc.
CY2020Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4164597
CY2020Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2020Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
1731 Embarcadero Rd.
CY2020Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q4 dei Local Phone Number
LocalPhoneNumber
276-7040
CY2020Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q4 dei Entity Shell Company
EntityShellCompany
true
CY2020Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
CY2020Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94303
CY2020Q4 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020Q4 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020Q2 dei Entity Public Float
EntityPublicFloat
0
CY2020Q4 dei Document Annual Report
DocumentAnnualReport
true
CY2020Q4 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020Q4 us-gaap Cash
Cash
150000
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
230653
CY2020Q4 us-gaap Assets
Assets
380653
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34395
CY2020Q4 gigu Notes Payable Related Parties Current
NotesPayableRelatedPartiesCurrent
125000
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
21
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
230333
CY2020Q4 us-gaap Liabilities
Liabilities
389749
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
895
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24105
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34096
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-9096
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
380653
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8952000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8952000
CY2020Q4 gigu Shares Forfeited Subsequent To Expiration Of Underwriters Over Allotment Option
SharesForfeitedSubsequentToExpirationOfUnderwritersOverAllotmentOption
1170000
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34096
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-34096
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2501357
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q4 us-gaap Profit Loss
ProfitLoss
-34096
CY2020Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24075
CY2020Q4 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
21
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10000
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
CY2020Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
125000
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
150000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
150000
CY2020Q4 gigu Deferred Offering Costs Included In Accounts Payable
DeferredOfferingCostsIncludedInAccountsPayable
10320
CY2020Q4 gigu Deferred Offering Costs Included In Accured Liabilites
DeferredOfferingCostsIncludedInAccuredLiabilites
220333
CY2020Q4 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which at times, may exceed federally insured limits. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2020Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020Q4 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-12-04
CY2020Q4 gigu Business Combination Proceeds From Issuance Initial Public Offering
BusinessCombinationProceedsFromIssuanceInitialPublicOffering
312000000
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
312000000
CY2020Q4 us-gaap Decommissioning Trust Assets Description
DecommissioningTrustAssetsDescription
The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes none of the funds held in the Trust Account will be released until the earlier of: (i) the completion of the Business Combination; (ii) the redemption of 100% of the public shares included in the public units (as defined below) sold in the Proposed Offering if the Company is unable to complete a Business Combination within 24 months from the closing of the Proposed Offering; or (iii) the redemption of the Public Shares in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if it does not complete the Business Combination within 24 months from the closing of the Proposed Offering.
CY2020Q4 gigu Minimum Percentage Of Fair Market Value Of Business Acquisition To Trust Account Balance
MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
0.80
CY2020Q4 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
239749
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 gigu Underwriters Over Allotment Option Period
UnderwritersOverAllotmentOptionPeriod
P45D
CY2020Q4 gigu Over Allotments Option To Purchase Additional Units
OverAllotmentsOptionToPurchaseAdditionalUnits
4680000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 gigu Underwriting Discount Per Unit Paid In Cash
UnderwritingDiscountPerUnitPaidInCash
0.20
CY2020Q4 gigu Deferred Underwriting Commissions Per Unit
DeferredUnderwritingCommissionsPerUnit
0.35
CY2020Q4 gigu Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
10920000
CY2020Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
156000
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1560000
CY2020Q4 gigu Share Issued Percentage
ShareIssuedPercentage
0.20
CY2020Q4 gigu Share Outstanding Percentage
ShareOutstandingPercentage
0.20
CY2020Q4 gigu Holding Period Of Shares For Completion Of Initial Business Combination
HoldingPeriodOfSharesForCompletionOfInitialBusinessCombination
P12M
CY2020Q4 gigu Number Of Trading Period For Transfer Of Shares
NumberOfTradingPeriodForTransferOfShares
P20D
CY2020Q4 gigu Number Of Consecutive Trading Period For Transfer Of Shares
NumberOfConsecutiveTradingPeriodForTransferOfShares
P30D
CY2020Q4 gigu Period After Completion Of Business Combination To Allow Transfer Of Shares
PeriodAfterCompletionOfBusinessCombinationToAllowTransferOfShares
P30D
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-34096
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-34096
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q4 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7160
CY2020Q4 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2381
CY2020Q4 gigu Valuation Allowance On Start Up Costs
ValuationAllowanceOnStartUpCosts
9541
CY2020Q4 gigu Start Up Costs
StartUpCosts
9541
CY2020Q4 gigu Valuation Allowance Costs
ValuationAllowanceCosts
9541
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9541
CY2020Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On February 8, 2021, the Company effected a 1.2:1 stock split of its common stock. All common stock share numbers and prices have been retroactively adjusted to reflect the stock split.
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0

Files In Submission

Name View Source Status
0001564590-21-017090-index-headers.html Edgar Link pending
0001564590-21-017090-index.html Edgar Link pending
0001564590-21-017090.txt Edgar Link pending
0001564590-21-017090-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gigu-10k_20201231.htm Edgar Link pending
gigu-20201231.xml Edgar Link completed
gigu-20201231.xsd Edgar Link pending
gigu-20201231_cal.xml Edgar Link unprocessable
gigu-20201231_def.xml Edgar Link unprocessable
gigu-20201231_lab.xml Edgar Link unprocessable
gigu-20201231_pre.xml Edgar Link unprocessable
gigu-ex1017_99.htm Edgar Link pending
gigu-ex1018_100.htm Edgar Link pending
gigu-ex311_11.htm Edgar Link pending
gigu-ex312_10.htm Edgar Link pending
gigu-ex321_8.htm Edgar Link pending
gigu-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending